Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

NCT05629208 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Cutaneous Lupus Erythematosus (CLE)

Interventions

DRUG: Edecesertib
DRUG: Edecesertib Placebo

Sponsor

Gilead Sciences